Products involved in the litigation include embolic protection devices and certain detachable embolic coils, which are medical devices related to cardiovascular diseases. Under the terms of the agreements
Boston Scientific said that it believes the finding of infringement is in error and that it will request the judge to overturn it. No damages were determined because
The primary objective of the microphthalmia transcription factor tumors trial is to determine the overall response rate in patients treated with the drug, ARQ 197. Secondary objectives include
Under the terms of the agreement, OakRiver has licensed the coating process know-how and other intellectual property of SurModics and will build highly automated equipment for medical device
The 30-week, open-label, noninferiority study included 295 subjects with type 2 diabetes who were not achieving adequate glucose control using diet and exercise with or without the use
The Phase II double-blind, randomized study is designed to evaluate the safety and efficacy of GSK961081 doses administered once daily for 14 days in a dry powder inhaler.
The new products from the Centrum brand will further enable individuals to customize their nutrition regimen to fit their health and well-being needs. New Formula Centrum has been
The purpose of the collaboration between Pharmasset and Genome Research Institute (GRI) is to identify active and selective compounds against antiviral targets for hepatitis B virus (HBV), hepatitis
Combigan is a prescription eye drop that works in two ways to reduce elevated intraocular pressure (IOP) and will be available to physicians in the fourth quarter of
NovaBay has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares at the initial public offering (IPO) price to cover over-allotments, if any.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.